The Presence of a CMV Immunodominant Allele in the Recipient Is Associated With Increased Survival in CMV Positive Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation-Reference-Cited by-同舟云学术

The Presence of a CMV Immunodominant Allele in the Recipient Is Associated With Increased Survival in CMV Positive Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation

Published:2019-09-17 Issue: Volume:9 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Grosso Dolores,Leiby Benjamin,Carabasi Matthew,Filicko-O'Hara Joanne,Gaballa Sameh,O'Hara William,Wagner John L.,Flomenberg Neal

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference53 articles.

1. CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia;Green;Blood,2013

2. Protective effect of cytomegalovirus reactivation on relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients is influenced by conditioning regimen;Manjappa;Biol Blood Marrow Transplant,2014

3. Potential beneficial effects of cytomegalovirus infection after transplantation;Litjens;Front Immunol,2018

4. Cytomegalovirus replication reduces the relapse incidence in patients with acute myeloid leukemia;Elmaagacli;Blood,2016

5. Cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation is associated with a reduced risk of relapse in patients with acute myeloid leukemia who survived to day 100 after transplantation: The Japan Society for hematopoietic cell transplantation transplantation-related complication working group;Takenaka;Biol Blood Marrow Transplant.,2015

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CMV reactivation during pretransplantation evaluation: a novel risk factor for posttransplantation CMV reactivation;Blood Advances;2024-08-29

2. Engineered HCMV‐infected APCs enable the identification of new immunodominant HLA‐restricted epitopes of anti‐HCMV T‐cell immunity;HLA;2024-06

3. Development and characterization of a cell donor registry for virus‐specific T cell manufacture in a blood bank;HLA;2024-03

4. The influence of HLA A, B, C, DR alleles and HLA haplotypes on cytomegalovirus‐specific cell mediated immunity in seropositive Korean kidney transplant candidates;HLA;2023-05-09

5. Impact of cytomegalovirus immunodominant HLA‐I donor–recipient matching on the incidence and features of virus DNAemia and virus‐specific T‐cell immune reconstitution in unmanipulated haploidentical hematopoietic stem cell transplantation;Transplant Infectious Disease;2023-04-30